What's the maximum safe daily NMN dose?

The highest dose tested in published human trials with safety reporting is 1,250mg/day in MIB-626 (Pencina 2023, 2025), a clinical-grade NMN formulation, given for 28 days without serious adverse events. Trials at 500mg/day are common (multiple Yoshino, Igarashi, and follow-up studies). Doses of 600-900mg appear in trials of athletic populations. Above 1,250mg/day, human safety data is sparse. The honest position is: 500mg/day is the well-trodden upper bound for general consumer use. 600-900mg/day is reasonable for athletic or larger-bodied users with a brand they trust. Above 1,000mg/day moves into territory where you are extrapolating beyond meaningfully replicated evidence. Side effects observed at higher doses are typically mild GI (nausea, soft stools) rather than serious organ toxicity - but absence of evidence is not evidence of absence at extreme doses. Practical Malaysian guidance: stay at or below 500mg/day unless you have a specific reason to escalate. Doubling capsule count to push 1,000mg-1,500mg/day mainly increases your monthly cost (RM700-RM1,000) without proportional benefit, since NMN's pharmacokinetics show saturation. If you are tempted to escalate, first verify the brand's COA, then move to a different brand at standard dose rather than megadosing one product. The 'more is better' instinct is a steroid-pharmacology habit that does not transfer well to NMN.

Why this matters for Malaysian buyers

NMN buying decisions in Malaysia involve a stack of considerations that don't always map to advice from US- or EU-focused sources: NPRA notification status, JAKIM halal certification (or its absence), tropical-climate storage realities, mall pharmacy versus Shopee Malaysia tradeoffs, and how local medical practitioners typically respond to questions about supplements outside their training. We answer questions like "What's the maximum safe daily NMN dose?" through the lens of Malaysian buyer realities - not generic global guidance.

Verify the source

This individual Q&A is a supporting note, not an indexable authority article. Health-relevant claims should be refreshed against the linked primary or official sources before they are used for buying or medical discussions.

• Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects (2022)
• Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021)
• Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men (2022)
• The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023)
• MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults (2023)
• National Pharmaceutical Regulatory Agency (NPRA) Malaysia - Quest3+ MAL Number Registry (2026)

Adjacent tools

Need to act on this answer? Try the halal checker, the cost calculator, the stack builder, or the brand selector quiz - each tool turns advice into actionable output for your specific situation.

More questions? Browse the full Q&A library (10 categories) · See our main FAQ · Browse NMN brand comparisons · NR brand comparisons.